None listed
Conditions
Interventions
Control Intervention1: NIL: NIL
Sponsors
Indian Counsil of Medical Research
Eligibility
Inclusion criteria
Inclusion criteria: we will be using only the archived specimens for the study we will not recruit any patients for the proposed study.
Exclusion criteria
Exclusion criteria: samples in-sufficiant, homolized, non-sera, positive for HIV and HBV will be excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proposed study will help in early differential diagnosis of JEV & WNV among patient who developing acute encephalitis. Designed study will also help in quantitative determination of IgM & IgG antibodies.Assay can be used to evaluate & monitor immune response to JEV, WNV, Dengue and Zika after vaccination or to understand seroprevalence. Assay can bring down cost, turnaround time and the biosafety concern compared to currently used PRNT or micro neutralization assay used for serological differentiation of JEV, Dengue and WNV.Timepoint: 2022-2024 | — |
Secondary
| Measure | Time frame |
|---|---|
| NATimepoint: NA | — |
Countries
India
Contacts
Public ContactSanthosha Devadiga
Father Muller Medical College
Outcome results
None listed